ID30117A - Antagonis 5ht1 untuk terapi anti depresan - Google Patents

Antagonis 5ht1 untuk terapi anti depresan

Info

Publication number
ID30117A
ID30117A IDW00200101401A ID20011401A ID30117A ID 30117 A ID30117 A ID 30117A ID W00200101401 A IDW00200101401 A ID W00200101401A ID 20011401 A ID20011401 A ID 20011401A ID 30117 A ID30117 A ID 30117A
Authority
ID
Indonesia
Prior art keywords
antagonists
depression therapy
anti depression
therapy
depression
Prior art date
Application number
IDW00200101401A
Other languages
English (en)
Indonesian (id)
Inventor
Gene Michael Braight
Kishor Amratlal Desai
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID30117A publication Critical patent/ID30117A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW00200101401A 1998-12-28 1999-11-03 Antagonis 5ht1 untuk terapi anti depresan ID30117A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11395798P 1998-12-28 1998-12-28

Publications (1)

Publication Number Publication Date
ID30117A true ID30117A (id) 2001-11-08

Family

ID=22352526

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101401A ID30117A (id) 1998-12-28 1999-11-03 Antagonis 5ht1 untuk terapi anti depresan

Country Status (43)

Country Link
US (1) US6525196B1 (es)
EP (1) EP1140931B1 (es)
JP (1) JP2002533463A (es)
KR (1) KR100417506B1 (es)
CN (1) CN1332740A (es)
AP (1) AP2001002188A0 (es)
AR (1) AR024840A1 (es)
AT (1) ATE260278T1 (es)
AU (1) AU761711B2 (es)
BG (1) BG105710A (es)
BR (1) BR9916807A (es)
CA (1) CA2356985C (es)
CO (1) CO5150179A1 (es)
CR (1) CR6398A (es)
CZ (1) CZ291163B6 (es)
DE (1) DE69915113T2 (es)
DK (1) DK1140931T3 (es)
DZ (1) DZ2933A1 (es)
EA (1) EA003099B1 (es)
EE (1) EE04439B1 (es)
ES (1) ES2214892T3 (es)
GE (1) GEP20043227B (es)
GT (1) GT199900224A (es)
HR (1) HRP20010488A2 (es)
HU (1) HUP0104852A3 (es)
ID (1) ID30117A (es)
IL (1) IL143385A0 (es)
IS (1) IS5951A (es)
MA (1) MA26706A1 (es)
NO (1) NO20013215L (es)
NZ (1) NZ511964A (es)
OA (1) OA11742A (es)
PA (1) PA8486701A1 (es)
PE (1) PE20001234A1 (es)
PT (1) PT1140931E (es)
SK (1) SK9002001A3 (es)
TN (1) TNSN99218A1 (es)
TR (1) TR200101979T2 (es)
TW (1) TW523514B (es)
UA (1) UA62015C2 (es)
WO (1) WO2000039128A1 (es)
YU (1) YU44301A (es)
ZA (1) ZA200105041B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60229123D1 (de) * 2001-02-20 2008-11-13 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
GB0203778D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
PL378749A1 (pl) * 2003-03-12 2006-05-15 Pfizer Products Inc. Azabicykliczne pochodne pirydyloksymetylowe i benzoizoksazolowe
GB0316915D0 (en) * 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
BRPI0507250A (pt) * 2004-01-29 2007-06-26 Pfizer Prod Inc combinações para tratar desordens do snc
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
EP1791541A2 (en) * 2004-09-10 2007-06-06 Pfizer Products Inc. Methods of treating mood disorders using benzisoxazole containing diazabicyclic compounds
JP2008512441A (ja) * 2004-09-10 2008-04-24 ファイザー・プロダクツ・インク ピリジルオキシメチル、及びベンズイソオキサゾール・アザビシクロ誘導体を使用する、認知障害の治療方法
DE102005026194A1 (de) * 2005-06-06 2006-12-07 Grünenthal GmbH Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
WO2008019431A1 (en) * 2006-08-14 2008-02-21 Brc Operations Pty Limited Method and compositions for simultaneously regulating memory and mood
EP2919788A4 (en) 2012-11-14 2016-05-25 Univ Johns Hopkins METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
AU2020407614A1 (en) * 2019-12-20 2022-08-18 The Jackson Laboratory Molecular targets for addiction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
US5756496A (en) * 1994-05-28 1998-05-26 Smithkline Beecham P.L.C. Amide derivatives having 5HT1D-antagonist activity
NZ500252A (en) * 1997-04-18 2001-07-27 Smithkline Beecham P 6-(4-Methyl-piperazin-1-yl)-1H-indole derivatives useful as 5HT1A, 5HT1B and 5HT1D receptor antagonists
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1

Also Published As

Publication number Publication date
GT199900224A (es) 2001-06-15
IL143385A0 (en) 2002-04-21
DZ2933A1 (fr) 2004-03-15
CR6398A (es) 2004-03-24
AU761711B2 (en) 2003-06-05
ATE260278T1 (de) 2004-03-15
CA2356985A1 (en) 2000-07-06
GEP20043227B (en) 2004-04-26
NO20013215D0 (no) 2001-06-27
DE69915113D1 (de) 2004-04-01
IS5951A (is) 2001-05-22
EP1140931A1 (en) 2001-10-10
EA003099B1 (ru) 2002-12-26
US6525196B1 (en) 2003-02-25
HUP0104852A3 (en) 2002-12-28
TW523514B (en) 2003-03-11
EA200100517A1 (ru) 2001-12-24
KR100417506B1 (ko) 2004-02-05
EP1140931B1 (en) 2004-02-25
CN1332740A (zh) 2002-01-23
AP2001002188A0 (en) 2001-06-30
CA2356985C (en) 2006-08-08
ZA200105041B (en) 2002-06-20
YU44301A (sh) 2004-07-15
MA26706A1 (fr) 2004-12-20
AU6361499A (en) 2000-07-31
CZ291163B6 (cs) 2003-01-15
CZ20012386A3 (cs) 2002-02-13
BG105710A (en) 2002-02-28
DE69915113T2 (de) 2004-08-26
UA62015C2 (en) 2003-12-15
HRP20010488A2 (en) 2002-08-31
PT1140931E (pt) 2004-05-31
HUP0104852A2 (hu) 2002-05-29
NO20013215L (no) 2001-08-27
DK1140931T3 (da) 2004-04-19
JP2002533463A (ja) 2002-10-08
EE200100346A (et) 2002-12-16
TR200101979T2 (tr) 2001-12-21
BR9916807A (pt) 2001-10-23
ES2214892T3 (es) 2004-09-16
SK9002001A3 (en) 2002-04-04
EE04439B1 (et) 2005-02-15
AR024840A1 (es) 2002-10-30
WO2000039128A1 (en) 2000-07-06
OA11742A (en) 2005-05-13
TNSN99218A1 (fr) 2005-11-10
PE20001234A1 (es) 2000-11-07
NZ511964A (en) 2003-08-29
KR20010092455A (ko) 2001-10-25
CO5150179A1 (es) 2002-04-29
PA8486701A1 (es) 2000-09-29

Similar Documents

Publication Publication Date Title
ID18003A (id) Antagonis muskarinik
DE69834019D1 (de) Dose
ATE314838T1 (de) Druckdosierinhalatoren
IS5487A (is) Innúðatæki
IS2780B (is) Innöndunartæki
ID22851A (id) Alat inhalasi
NO20004688L (no) Terapi ved østrogenassosierte lidelser
IS5760A (is) Meðferðarlegar bíarýl afleiður
EE03903B1 (et) Omeprasooli ravimvorm
NO20010556L (no) Fremgangsmate for oftalmisk administrering
ID19623A (id) Antagonis reseptor vitronektin
NO992692D0 (no) Nefadozon doseringsform
EE200000171A (et) Uued NPY antagonistid
ID30117A (id) Antagonis 5ht1 untuk terapi anti depresan
ID26223A (id) Antagonis reseptor vitronektin
ID29128A (id) Gen untuk biosintesis epotilon
ID26665A (id) Antagonis vla-4
ID29914A (id) Senyawa benzensulfonamida heterosiklik sebagai antagonis bradikinin
ID26086A (id) Ligan-ligan reseptor 5ht1 azabisiklik
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
DE69921275D1 (de) Inhalationsgerät
ID28811A (id) Antagonis reseptor vitronektin
NO990717D0 (no) Monitor-st°ttemekanisme
NO20012226L (no) Terapeutiske midler for medikamentavhengighet